The Biggest Bottlenecks Holding Back Cell and Gene Therapy

Aug 24, 2026

Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges

Read more here: The Medicine Maker

Recent News